CASP3 and neoplasm: Studies have found [45] that histone deacetylase inhibitors can inhibit the formation of reactive oxygen species in tumor cells, promote the activation of caspase-8, caspase-9, caspase-3 and PARP, and ultimately lead to cell apoptosis.